Finland· FI-REL-REL43427

TachoSil

A lokale hämostatika, kombinationen product containing human thrombin + human fibrinogen, registered in Finland by Orifarm Oy. The same ATC class is registered in 11 of our 19 countries.

ATC B02BC30

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTachoSilATCB02BC30REGISTER NO.FI-REL-REL43427PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Lokale hämostatika, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 7 of them publish a price we can compare per daily dose

Lokale hämostatika, kombinationen · ATC B02BC30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Human thrombin + Human fibrinogen
Manufacturer
Orifarm Oy
Country
Finland (FI)
ATC code
B02BC30
ATC class
Lokale Hämostatika, Kombinationen
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lokale hämostatika, kombinationen in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lokale hämostatika, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e60688c9-758f-4e35-a40c-57ba8e35c6f5
GET /v1/drugs/e60688c9-758f-4e35-a40c-57ba8e35c6f5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "kudosliimamatriksi",
  "route": "Kudosvaurion päälle",
  "ddd_unit": null,
  "strength": null,
  "atc_label": "yhdistelmävalmisteet",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/04/277/01-03",
  "fimea_rel_id": "REL43427",
  "authorised_at": "2013-03-14"
}

See everything about lokale hämostatika, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.